RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2022)
RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4,839.00 |
| Sep 30, 2022 | 5,373.00 |
| Jun 30, 2022 | -162.00 |
| Mar 31, 2022 | 2,758.00 |
| Dec 31, 2021 | -834.00 |
| Sep 30, 2021 | -4,495.00 |
| Jun 30, 2021 | -1,606.00 |
| Mar 31, 2021 | 92,395.00 |
| Dec 31, 2020 | 81,122.00 |
| Sep 30, 2020 | 59,176.00 |
| Jun 30, 2020 | 58,877.00 |
| Mar 31, 2020 | -54,981.00 |
| Dec 31, 2019 | -26,761.00 |
| Sep 30, 2019 | -25,539.00 |
| Jun 30, 2019 | -30,327.00 |
| Mar 31, 2019 | -4,548.00 |
| Dec 31, 2018 | 10,522.00 |
| Sep 30, 2018 | 31,097.00 |
| Jun 30, 2018 | 163,564.00 |
| Mar 31, 2018 | -20.68 Mn |